Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

Author： Supply P. Sutton P. Coughlan S.N. Bilo K. Saman E. Trees A.J. Cesbron Delauw M.-F. Locht C.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.7, 1999-02, pp. : 705-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene

By Desolme B. Mevelec M.-N. Buzoni-Gatel D. Bout D.

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2512-2521

Elsevier

Access to resources Recommend Favorite

DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

By Couper K.N. Nielsen H.V. Petersen E. Roberts F. Roberts C.W. Alexander J.

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2813-2820

Elsevier

Access to resources Recommend Favorite

Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum

By Zheng C. Xie P. Chen Y.

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 914-919

Elsevier

Access to resources Recommend Favorite

Immunization with E. coli produced recombinant T. bondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii

By Petersen E. Nielsen H.V. Christiansen L. Spenter J.

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1283-1289

Elsevier

Access to resources Recommend Favorite

Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2

By Jones G.L. Spencer L. Lord R. Saul A.J.

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 77-84

Elsevier

Access to resources Recommend Favorite